ESC/ERS 2022 Guidelines — Pulmonary Hypertension
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
The 2022 guideline lowered the haemodynamic threshold — a mean pulmonary artery pressure above 20 mmHg, with pulmonary vascular resistance above 2 Wood units defining the precapillary component. Questions frequently hand you a full catheterisation data set and ask you to classify before treating, because the classification determines whether targeted therapy is indicated at all.
That is the single most productive theme here. Drugs approved for pulmonary arterial hypertension are not for pulmonary hypertension due to left heart disease, and specific agents are contraindicated in the lung disease group. A question that offers a plausible vasodilator for a patient with a raised wedge pressure is testing group assignment, not pharmacology.
The rest: risk stratification at diagnosis and at follow-up, the escalation that follows from an intermediate or high risk category, combination therapy and its sequence, chronic thromboembolic disease and its surgical and interventional options, and the paediatric and pregnancy recommendations.
What is in the bank
184 active questions. Class and level follow the recommendation each question is built from.